Senior insider sale
Chief Medical Officer at UROGEN PHARMA LTD. — senior position signals high conviction
$300.0K
10K shares
What this filing means
SCHOENBERG MARK plans to sell 10K shares of UROGEN PHARMA LTD. valued at approximately $300.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/8/2026ACC: 0001000275-26-000047
Officer· Chief Medical Officer
Since Jan 2019
10K
Shares to sell
$300.0K
Approx. market value
10K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
OPTION EXERCISE
N/A
1/27/2023
10KTotal acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/27/2023 | OPTION EXERCISE N/A | 10K | — |
| Total | 10K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
10K
Market value
$300.0K
5/8/2026
Total
Units
10K
Value
$300.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/8/2026 | 10K | $300.0K | NASDAQ | Planned |
| Total | 10K | $300.0K | ||